BUY Akums Drugs and Pharmaceuticals — Sumeet Bagadia, 15 Sept 2026

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Swing (≤2wk))15 Sept 2026via LiveMint Buy-or-Sell (topic)

Entry₹776Stated

Target₹865

Stop loss₹734-5.41% risk

CMP₹765.65Just now

Active-1.33%+12.98%upside left 13d left

Follow Sumeet Bagadia for new calls(30% target hit, 290 closed calls)Get alerts Watch AKUMS for new buy/sell callsGet alerts See 1 other Swing call on AKUMS See 63 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Sept, 4:04 pm IST

2 supporting1 opposing

Supports the BUY call (2)

Akums Drugs Q1FY27 net profit surges 56%; concall flags API turnaround

NewsGoogle News·14 Sept · today

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·15 Sept · today

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·15 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Akums Drugs and Pharmaceuticals — Sumeet Bagadia, Choice Broking

AI Assessment